Clinical Trials in Type 2 Diabetes : NIDDK

Clinical Trials in Type 2 Diabetes

The Type 2 Diabetes Clinical Trials Program will focus on patient-oriented research (i.e., clinical studies and small clinical trials) related to pharmacologic interventions and/or lifestyle interventions to prevent or treat Type 2 Diabetes.

For further information on Type 2 Diabetes in the Pediatric Population contact Barbara Linder, M.D., Ph.D. Senior Advisor for Childhood Diabetes Research.

For information on Type 2 Diabetes in the Adult Population contact Myrlene Staten, M.D., Senior Advisor for Diabetes Research Translation.

For further information on Behavioral/Prevention Research in Diabetes and/or the Diabetes Prevention Program (DPP), contact Sanford Garfield, Ph.D., Senior Advisor for Biometry and Behavioral Research.

For more information, contact Dr. Sandy Garfield, Senior Advisor for Biometry and Behavioral Research Program.

Resources for Researchers

Clinical Research

Centers

Diabetes Center Programs - Overview & Map

Committees and Advisory Groups

Diabetes Mellitus Interagency Coordinating Committee (DMICC)

Related Study Sections

NIDDK Staff

Dr. Kristin Abraham, Cell Signaling and Diabetes Centers Program Director
Dr. Beena Akolkar, Immunopathogenesis and Genetics of Type 1 Diabetes Program Director
Dr. Michael Appel, Director, Islet Biology and Transplantation Research Program
Dr. Guillermo Arreaza-Rubin, Director, Clinical Immunology, Type 1 Diabetes Program
Dr. Olivier Blondel, Director, Endocrine Systems Biology Program
Dr. Arthur Castle, Director, Metabolomics and Informatics Programs
Dr. Catherine Cowie, Director, Diabetes Epidemiology Program
Dr. Thomas Eggerman, Director, Islet Transplantation Clinical Trials Program
Dr. Judith Fradkin, Director, Division of Diabetes, Endocrinology, and Metabolic Diseases
Dr. Sandy Garfield, Senior Advisor for Biometry and Behavioral Research Program
Dr. Carol Haft, Senior Advisor for Cell Biology, Associate Director for Grants Administration
Dr. Christine Hunter, DEM, Director, Diabetes and Obesity Behavioral Research Program
Dr. James Hyde, Senior Advisor, Research Training and Career Development Programs
Dr. Teresa Jones, Diabetes Complications Program Director
Dr. Chris Ketchum, Basic Renal Biology Program Director
Dr. Maren Laughlin, Senior Advisor for Integrative Metabolism
Dr. Ellen Leschek, Type 1 Diabetes Trialnet Program Director
Dr. Barbara Linder, Senior Advisor for Childhood Diabetes Research
Dr. Saul Malozowski, Senior Advisor for Endocrine Physiology
Dr. Ronald Margolis, Senior Advisor, Molecular Endocrinology
Dr. Catherine McKeon, Senior Advisor for Genetic Research in Diabetes, Endocrinology and Metabolic Diseases
Dr. Catherine Meyers, Inflammatory Kidney Diseases Program Director
Dr. Sheryl Sato , Director, Neurobiology of Obesity and Developmental Biology
Dr. Salvatore Sechi, Proteomic Program Director
Dr. Philip Smith, Deputy Director of the Division of Diabetes, Endocrinology and Metabolism, Co-Director, Office of Obesity Research
Dr. Lisa Spain, Director, Immunobiology of Type 1 Diabetes Program and Autoimmune Endocrine Diseases Program
Dr. Myrlene Staten, Senior Advisor, Diabetes Research Translation
Karen Salomon, Program Analyst

Funding Opportunities

Funding for Special Communities

Conferences

Related Reports

The Type 1 Diabetes Research Strategic Plan
Conquering Diabetes: A Strategic Plan for the 21st Century
- Full Report and
- Report Summary and Recommendations from the Diabetes Research Working Group (1999)
Evaluation Report on the Special Statutory Funding Program for Type 1 Diabetes Research
Report on Closing the Disparity Between Hemoglobin A1c Guidelines and Practice
Report on Progress and Opportunities: Special Statutory Funding for Type 1 Diabetes Research

The National Institute of Diabetes & Digestive & Kidney Diseases

Scientific Programs

Funding for Special Communities